Literature DB >> 10359767

On the structure of endogenous ouabain.

A Kawamura1, J Guo, Y Itagaki, C Bell, Y Wang, G T Haupert, S Magil, R T Gallagher, N Berova, K Nakanishi.   

Abstract

The ouabain-like sodium pump inhibitor in mammals (so-called "endogenous ouabain") has been considered a subtle structural isomer of ouabain. Its structural investigation, however, has long been hindered by the paucity of sample material. Our recent purification of endogenous ouabain (3 micrograms) from bovine hypothalamus allowed the measurement of its 1H-NMR. The obtained spectrum as well as reexamination of past microscale structural studies on endogenous ouabain led us to identify the purified material as ouabain in an unusual manner. It turned out that the structural analysis had been complicated by a facile ouabain-borate complexation in borosilicate glassware. In retrospect, it is not surprising that the polyhydroxylated ouabain molecule serves as a polydentate ligand to inorganic species. In its physiological environment, ouabain may exist as some unknown complex. The chemical species giving rise to the reported biological activities of hypothalamic inhibitory factor preparations remain to be clarified.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359767      PMCID: PMC21970          DOI: 10.1073/pnas.96.12.6654

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Evidence for an endogenous ouabain-like immunoreactive factor in human newborn plasma coeluted with ouabain on HPLC.

Authors:  V Di Bartolo; S Balzan; L Pieraccini; S Ghione; S Pegoraro; P Biver; R Revoltella; U Montali
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

Review 2.  Ouabain-like factor.

Authors:  A Goto; K Yamada
Journal:  Curr Opin Nephrol Hypertens       Date:  1998-03       Impact factor: 2.894

Review 3.  Endogenous inhibitors of the Na,K pump.

Authors:  P A Doris
Journal:  Miner Electrolyte Metab       Date:  1996

4.  Ouabain is not detectable in human plasma.

Authors:  L K Lewis; T G Yandle; J G Lewis; A M Richards; G B Pidgeon; R J Kaaja; M G Nicholls
Journal:  Hypertension       Date:  1994-11       Impact factor: 10.190

5.  High-affinity monoclonal antibodies to the cardiac glycoside, digoxin.

Authors:  M M Hunter; M N Margolies; A Ju; E Haber
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

Review 6.  Franz Volhard Lecture 1996. Sodium transport inhibitors and hypertension.

Authors:  H E de Wardener
Journal:  J Hypertens Suppl       Date:  1996-12

7.  Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays.

Authors:  M Ferrandi; P Manunta; S Balzan; J M Hamlyn; G Bianchi; P Ferrari
Journal:  Hypertension       Date:  1997-10       Impact factor: 10.190

8.  Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump.

Authors:  R Schneider; V Wray; M Nimtz; W D Lehmann; U Kirch; R Antolovic; W Schoner
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

9.  Na,K-ATPase inhibitor from guinea pig brain is not ouabain-like.

Authors:  G R Kracke
Journal:  J Lab Clin Med       Date:  1983-01

10.  Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis.

Authors:  N Zhao; L C Lo; N Berova; K Nakanishi; A A Tymiak; J H Ludens; G T Haupert
Journal:  Biochemistry       Date:  1995-08-08       Impact factor: 3.162

View more
  30 in total

1.  High-affinity ouabain binding by a chimeric gastric H+,K+-ATPase containing transmembrane hairpins M3-M4 and M5-M6 of the alpha 1-subunit of rat Na+,K+-ATPase.

Authors:  J B Koenderink; H P Hermsen; H G Swarts; P H Willems; J J De Pont
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Ouabain modulates ciliogenesis in epithelial cells.

Authors:  Isabel Larre; Aida Castillo; Catalina Flores-Maldonado; Ruben G Contreras; Ivan Galvan; Jesus Muñoz-Estrada; Marcelino Cereijido
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

3.  Ouabain modulates epithelial cell tight junction.

Authors:  Isabel Larre; Amparo Lazaro; Ruben G Contreras; Maria S Balda; Karl Matter; Catalina Flores-Maldonado; Arturo Ponce; David Flores-Benitez; Ruth Rincon-Heredia; Teresita Padilla-Benavides; Aída Castillo; Liora Shoshani; Marcelino Cereijido
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-04       Impact factor: 11.205

Review 4.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 5.  Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease.

Authors:  Mordecai P Blaustein; Ling Chen; John M Hamlyn; Frans H H Leenen; Jerry B Lingrel; W Gil Wier; Jin Zhang
Journal:  J Physiol       Date:  2016-07-31       Impact factor: 5.182

6.  Na,K-ATPase is the putative membrane receptor of hormone ouabain.

Authors:  Isabel Larre; Marcelino Cereijido
Journal:  Commun Integr Biol       Date:  2010-11-01

Review 7.  How does pressure overload cause cardiac hypertrophy and dysfunction? High-ouabain affinity cardiac Na+ pumps are crucial.

Authors:  Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-21       Impact factor: 4.733

Review 8.  Livin' with NCX and lovin' it: a 45 year romance.

Authors:  Mordecai P Blaustein
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

9.  Ouabain attenuates ovalbumin-induced airway inflammation.

Authors:  José Guilherme F M Galvão; Luiz Henrique Agra Cavalcante-Silva; Deyse Cristina M Carvalho; Laércia Karla D P Ferreira; Talissa Mozzini Monteiro; Adriano Francisco Alves; Larissa Adilis M P Ferreira; Francisco Allysson A F Gadelha; Marcia Regina Piuvezam; Sandra Rodrigues-Mascarenhas
Journal:  Inflamm Res       Date:  2017-09-13       Impact factor: 4.575

Review 10.  Endogenous Ouabain: Recent Advances and Controversies.

Authors:  John M Hamlyn; Mordecai P Blaustein
Journal:  Hypertension       Date:  2016-07-25       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.